Mydecine

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Jul 21, 2021

Mydecine Innovations Group Announces Launch of Mindleap Version 2.0

Jul 13, 2021

Mydecine CEO Josh Bartch Speaks on Psilocybin and Smoking Cessation

Jul 8, 2021

TDR’s Top 5 Psychedelic Developments For The Week Of June 21

Jun 26, 2021

Mydecine Unveils Artificial Intelligence Drug Discovery Program

Jun 16, 2021

TDR’s Top 5 Psychedelic Developments For The Week Of June 7

Jun 12, 2021

Getting People to Help Changes Everything: William Cook, CEO of MindLeap

Jun 11, 2021

8 Stocks for Investors Interested in the Potential of Magic Mushrooms

Jun 9, 2021

Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

Jun 8, 2021

Microdosing, PTSD and Research: Mydecine COO Damon Michaels Talks Psychedelics

Jun 3, 2021